Infectious Disease Clinical Research Physician

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana, working to discover and bring life‑changing medicines, improve disease understanding and management, and give back through philanthropy and volunteerism. Position Overview Eli Lilly and Company seeks an experienced and passionate Infectious Disease Clinical Research Physician to contribute to the development of novel therapies. The role involves designing, executing, and interpreting clinical trials for infectious diseases, ensuring scientific rigor and ethical conduct. Responsibilities Design and develop clinical trial protocols, statistical analysis plans, and other essential study documents for infectious disease programs. Serve as a medical expert for assigned clinical trials, providing medical input and oversight throughout the study lifecycle, including site selection, investigator meetings, and data review. Monitor and interpret clinical trial data, identify safety signals, efficacy trends, and potential issues, and propose appropriate actions. Lead and participate in interactions with regulatory authorities (e.g., FDA, EMA) regarding clinical trial design, data submission, and labeling. Collaborate effectively with cross‑functional teams—preclinical research, biostatistics, regulatory affairs, clinical operations, and commercial—to support study objectives. Contribute to the preparation of clinical study reports, publications, and presentations at scientific conferences. Provide medical expertise and guidance to internal project teams and external investigators. Stay abreast of scientific and clinical developments in infectious diseases and clinical research methodology. Ensure compliance with all applicable regulations, Good Clinical Practice (GCP), and company standard operating procedures (SOPs). Basic Qualifications Medical Doctor (M.D.) or Doctor of Osteopathy (D.O.). Non‑U.S. trained physicians must have completed education and training at a medical school that meets the Liaison Committee on Medical Education (LCME) requirements. Must be board eligible or certified in the appropriate specialty/subspecialty or have completed the comparable level of post‑medical school clinical training in the country of hiring. U.S. trained physicians must have achieved board eligibility or certification. Minimum of 5 years of experience in clinical research within the pharmaceutical industry or academic research setting. Additional Preferences Board eligibility or certification in pediatric or adult infectious disease is highly desirable. Significant experience focusing on infectious diseases in pharmaceutical or academic research. Demonstrated experience in designing, conducting, and interpreting Phase 1, 2, or 3 clinical trials. Strong understanding of drug development processes, regulatory requirements, and GCP guidelines. Excellent communication, interpersonal, and presentation skills. Ability to work independently and collaboratively in a fast‑paced, matrixed environment. Proven ability to critically analyze and interpret complex scientific and clinical data. Experience with global clinical trials is highly desirable. Publications in peer‑reviewed medical journals are a plus. Compensation and Benefits Actual compensation will depend on education, experience, skills, and geographic location. The anticipated salary range is $243,000 – $389,400 annually. Full‑time employees are eligible for a company bonus and a comprehensive benefits program that includes 401(k), pension, vacation, medical, dental, vision, prescription drug coverage, flexible spending accounts, life insurance, and various well‑being benefits. Lilly is an equal opportunity employer. We do not discriminate on the basis of age, race, color, religion, gender identity, sex, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status. #J-18808-Ljbffr Initial Therapeutics, Inc.